Hybrid imaging and women’s health

Molecular Imaging Insight, April 7, 2008
Diagnosing heart disease in women is sometimes difficult, but molecular PET and SPECT imagin is beginning to contribute to resolving the problem, writes Johannes Czernin, MD, a professor of Molecular and Medical Pharmacology at UCLA. PET/CT's ability to correct for soft tissue attentuation, and its excellent spatial and temporal resolution allows it to quantify blood flow in the various regions of the heart. With SPECT/CT, appropriate soft-tissue attentuation is now possible, reducing the number of false positive findings, Czernin writes.

MOST POPULAR

SPONSORED REPORTS
SPONSORED HEADLINES

SIGN UP

FREE e-Newsletters Join the Council Subscribe to HL magazine

SPONSORSHIP & ADVERTISING

100 Winners Circle Suite 300
Brentwood, TN 37027

800-727-5257

About | Advertise | Terms of Use | Privacy Policy | Reprints/Permissions | Contact
© HealthLeaders Media 2014 a division of BLR All rights reserved.